RCEL
AVITA Medical, Inc.
Company overview
- Market capitalization
- —
- Employees
- 226
- Latest publication
- 2026-09-29
About AVITA Medical, Inc.
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company sells and distributes PermeaDerm, a biosynthetic wound matrix and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q4 20212021-12-31 · AUD | Q4 20202020-12-31 · AUD | Q3 20202020-09-30 · AUD | Q2 20202020-06-30 · AUD | Q2 20192019-06-30 · AUD | Q1 20192019-03-31 · AUD | Q3 20182018-09-30 · AUD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 21,702,000USD | 6,936,000AUD | 5,103,000AUD | 5,060,000AUD | 3,877,000AUD | 2,994,132AUD | 2,948,984AUD | 906,618AUD |
| Cost Of Revenue | 3,935,000USD | 817,000AUD | 821,000AUD | 929,000AUD | 874,000AUD | 619,397AUD | 610,058AUD | 285,164AUD |
| Gross Profit | 17,767,000USD | 6,119,000AUD | 4,282,000AUD | 4,131,000AUD | 3,003,000AUD | 2,374,735AUD | 2,338,926AUD | 621,454AUD |
| Research Development | 5,078,000USD | 4,198,000AUD | 3,361,000AUD | 3,374,000AUD | 1,835,000AUD | 2,223,878AUD | 2,004,393AUD | 3,540,106AUD |
| Selling And Marketing Expenses | 13,573,000USD | 4,954,000AUD | 3,600,000AUD | 3,265,000AUD | 3,367,000AUD | 3,679,331AUD | 3,383,331AUD | 3,465,704AUD |
| General And Administrative Expenses | 5,971,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 24,622,000USD | 14,593,000AUD | 9,913,000AUD | 14,345,000AUD | 16,026,000AUD | 20,630,871AUD | 20,319,785AUD | 10,960,376AUD |
| Operating Income | -6,855,000USD | -8,474,000AUD | -5,631,000AUD | -10,214,000AUD | -13,023,000AUD | -18,256,136AUD | -17,980,859AUD | -10,338,921AUD |
| Total Other Income Expense Net | -775,000USD | 14,000AUD | 1,000AUD | -3,000AUD | 113,000AUD | 8,127,723AUD | 8,005,170AUD | 2,549,038AUD |
| Interest Expense | 1,463,000USD | 11,000AUD | 3,000AUD | 7,000AUD | 8,000AUD | 64,402AUD | 63,430AUD | 5,349AUD |
| Income Before Tax | -7,630,000USD | -8,460,000AUD | -5,630,000AUD | -10,217,000AUD | -12,910,000AUD | -10,128,412AUD | -9,975,689AUD | -7,789,883AUD |
| Income Tax Expense | 33,000USD | 19,000AUD | 11,000AUD | 10,000AUD | 4,000AUD | -86,532AUD | -85,227AUD | 0AUD |
| Net Income | -7,663,000USD | -8,479,000AUD | -5,641,000AUD | -10,227,000AUD | -12,914,000AUD | -10,041,880AUD | -9,890,461AUD | -7,789,883AUD |
| Selling General Administrative | — | 4,900,000AUD | 3,401,000AUD | 8,302,000AUD | 11,305,000AUD | 8,398,043AUD | 15,773,472AUD | 3,432,707AUD |
| Net Interest Income | — | -8,000AUD | -3,000AUD | -7,000AUD | -8,000AUD | — | — | — |
| Tax Provision | — | 19,000AUD | 11,000AUD | 10,000AUD | 4,000AUD | -179,860AUD | — | — |
| Net Income From Continuing Ops | — | -8,479,000AUD | -5,641,000AUD | -10,227,000AUD | -12,914,000AUD | -183,414AUD | -230,475AUD | -5,627,580AUD |
| Ebit | — | -8,457,000AUD | -5,627,000AUD | -10,210,000AUD | -13,112,000AUD | -10,301,436AUD | -10,146,104AUD | -7,834,292AUD |
| Ebitda | — | -8,300,000AUD | -5,465,000AUD | -9,999,000AUD | -12,902,000AUD | -10,205,250AUD | -10,107,365AUD | -7,798,405AUD |
| Depreciation And Amortization | — | 157,000AUD | 162,000AUD | 211,000AUD | 210,000AUD | 96,186AUD | 38,739AUD | 35,887AUD |
| Net Income Applicable To Common Shares | — | -8,479,000AUD | -5,641,000AUD | -10,227,000AUD | -13,772,254AUD | -9,790,418AUD | -9,790,418AUD | -5,627,580AUD |
| Reconciled Depreciation | — | — | 162,000AUD | 211,000AUD | — | — | — | — |
| Unclassified Operating Expenses | — | — | — | — | — | 6,329,619AUD | — | — |
| Non Operating Income Net Other | — | — | — | — | — | 0AUD | 0AUD | 0AUD |
| Minority Interest | — | — | — | — | — | 0AUD | 0AUD | 0AUD |
| Discontinued Operations | — | — | — | — | — | 0AUD | 0AUD | 0AUD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20222022-06-30 · AUD | FY 20162016-12-31 · AUD | FY 20132013-12-31 · AUD | FY 20122012-12-31 · AUD | FY 19991999-12-31 · AUD | FY 19961996-12-31 · AUD | FY 19941994-12-31 · AUD | FY 19931993-12-31 · AUD |
|---|---|---|---|---|---|---|---|---|
| Interest Expense | 0AUD | 9,801AUD | 24,172AUD | 83AUD | 885,068AUD | 343,016AUD | 1,025AUD | 282,246AUD |
| Income Tax Expense | 42,000AUD | -805,518AUD | -1,474,747AUD | -116,862AUD | 885,068AUD | -772,204AUD | -315,886AUD | 308,269AUD |
| Ebit | -25,076,000AUD | -16,544,767AUD | -7,258,269AUD | -9,332,405AUD | -361,949AUD | -184,317AUD | -368,192AUD | -307,267AUD |
| Net Income Applicable To Common Shares | -25,142,000AUD | -11,511,024AUD | — | — | — | — | — | — |
| Total Revenue | — | 1,541,669AUD | 2,855,792AUD | 3,042,957AUD | — | — | — | — |
| Cost Of Revenue | — | 660,259AUD | 714,064AUD | 731,287AUD | — | — | — | — |
| Gross Profit | — | 881,409AUD | 2,141,726AUD | 2,311,669AUD | — | — | — | — |
| Research Development | — | 6,293,846AUD | 2,159,705AUD | 2,573,980AUD | — | — | — | — |
| Selling General Administrative | — | 11,360,802AUD | 5,482,071AUD | 5,048,477AUD | 361,949AUD | 184,317AUD | 368,192AUD | 307,268AUD |
| Unclassified Operating Expenses | — | 2,591,438AUD | — | — | — | — | — | — |
| Total Operating Expenses | — | 20,246,086AUD | 9,275,114AUD | 11,403,762AUD | 361,949AUD | 184,317AUD | 368,192AUD | 307,268AUD |
| Operating Income | — | -16,544,768AUD | -7,258,270AUD | -9,332,405AUD | -361,949AUD | -184,317AUD | -368,192AUD | -307,268AUD |
| Interest Income | — | 95,064AUD | — | — | — | — | — | — |
| Net Interest Income | — | 85,263AUD | — | — | — | — | — | — |
| Income Before Tax | — | -16,399,883AUD | -7,087,625AUD | -8,886,756AUD | -1,247,017AUD | 244,871AUD | -2,877,850AUD | -25,021AUD |
| Tax Provision | — | -805,518AUD | — | — | — | — | — | — |
| Net Income | — | -15,031,095AUD | -5,478,625AUD | -8,748,331AUD | -1,247,017AUD | 244,871AUD | -2,561,963AUD | -333,290AUD |
| Net Income From Continuing Ops | — | -8,845,652AUD | — | — | — | — | — | — |
| Ebitda | — | -16,362,343AUD | -7,190,459AUD | -9,200,608AUD | 552,285AUD | 584,461AUD | -368,192AUD | -234,204AUD |
| Depreciation And Amortization | — | 182,424AUD | 67,810AUD | 131,797AUD | 914,234AUD | 768,778AUD | -2,586,578AUD | 73,063AUD |
| Reconciled Depreciation | — | 139,703AUD | — | — | — | — | — | — |
| Total Other Income Expense Net | — | 144,885AUD | 170,644AUD | 445,649AUD | -870,823AUD | 2,023,553AUD | 131,277AUD | 158,487AUD |
| Non Operating Income Net Other | — | 0AUD | — | — | — | — | — | — |
| Minority Interest | — | 0AUD | — | — | — | — | — | — |
| Discontinued Operations | — | 0AUD | — | — | — | — | — | — |
| Selling And Marketing Expenses | — | — | 2,479,351AUD | 3,094,316AUD | — | — | — | — |
| Other Operating Expenses | — | — | — | — | 361,949AUD | 184,317AUD | 368,192AUD | 307,268AUD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 47,777,000USD | 51,544,000USD | 56,392,000USD | 63,728,000USD | 58,134,000USD | 69,556,000USD | 79,711,000USD | 81,051,000USD |
| Cash And Equivalents | 9,139,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 11,135,000USD | 14,261,000USD | 18,185,000USD | 23,313,000USD | 15,690,000USD | 25,818,000USD | 35,885,000USD | 44,405,000USD |
| Short Term Investments | 1,996,000USD | 5,952,000USD | 7,942,000USD | 7,891,000USD | 3,474,000USD | 10,948,000USD | 21,835,000USD | 25,766,000USD |
| Total Current Assets | 28,394,000USD | 31,647,000USD | 35,490,000USD | 41,367,000USD | 36,253,000USD | 47,967,000USD | 57,000,000USD | 63,925,000USD |
| Other Current Assets | 2,105,000USD | 1,372,000USD | 1,272,000USD | 1,769,000USD | 1,374,000USD | 1,606,000USD | 3,822,000USD | — |
| Other Non Current Assets | 593,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 75,615,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 68,714,000USD | 66,671,000USD | 62,677,000USD | 61,831,000USD | 62,602,000USD | 22,956,000USD | 20,158,000USD | 17,141,000USD |
| Other Current Liabilities | 3,305,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | -27,838,000USD | -23,166,000USD | -16,650,000USD | -6,666,000USD | -12,892,000USD | -4,571,000USD | 4,499,000USD | 12,227,000USD |
| Total Equity Including Noncontrolling Interest | -27,838,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 46,659,000USD | 46,139,000USD | 42,984,000USD | 42,449,000USD | 42,216,000USD | — | — | — |
| Deferred Revenue Non Current | 273,000USD | — | — | — | — | — | — | — |
| Net Receivables | 9,867,000USD | 9,897,000USD | 9,107,000USD | 9,045,000USD | 11,653,000USD | 12,148,000USD | 11,963,000USD | 13,291,000USD |
| Property Plant Equipment Net | 10,333,000USD | 10,877,000USD | 11,529,000USD | 13,012,000USD | 12,821,000USD | 13,250,000USD | 13,589,000USD | 12,931,000USD |
| Intangible Assets | 5,249,000USD | 5,442,000USD | 5,645,000USD | 5,204,000USD | 5,308,000USD | 5,447,000USD | 5,570,000USD | 590,000USD |
| Accounts Payable | 6,423,000USD | 7,220,000USD | 8,959,000USD | 8,107,000USD | 7,267,000USD | 8,677,000USD | 6,294,000USD | 4,187,000USD |
| Common Stock | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD |
| Retained Earnings | -426,675,000USD | -419,012,000USD | -408,401,000USD | -396,780,000USD | -383,593,000USD | -373,673,000USD | -359,814,000USD | -348,225,000USD |
| Accumulated Other Comprehensive Income | -82,000USD | 648,000USD | -1,367,000USD | -1,390,000USD | -2,079,000USD | -413,000USD | -1,939,000USD | -2,065,000USD |
| Total Liab | — | 74,710,000USD | 73,042,000USD | 70,394,000USD | 71,026,000USD | 74,127,000USD | 75,212,000USD | 68,824,000USD |
| Other Current Liab | — | 13,312,000USD | 9,805,000USD | 11,275,000USD | 13,119,000USD | 14,279,000USD | 12,964,000USD | 12,954,000USD |
| Capital Stock | — | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD |
| Cash | — | 8,309,000USD | 10,243,000USD | 15,422,000USD | 12,216,000USD | 14,870,000USD | 14,050,000USD | 18,639,000USD |
| Net Debt | — | 39,811,000USD | 35,805,000USD | 29,351,000USD | 32,372,000USD | 29,203,000USD | 31,935,000USD | 26,987,000USD |
| Short Term Debt | — | 46,139,000USD | 43,913,000USD | 42,449,000USD | 42,216,000USD | — | 900,000USD | — |
| Short Long Term Debt Total | — | 48,120,000USD | 46,048,000USD | 44,773,000USD | 44,588,000USD | 44,073,000USD | 45,985,000USD | 45,626,000USD |
| Inventory | — | 6,117,000USD | 6,926,000USD | 7,240,000USD | 7,536,000USD | 8,395,000USD | 7,269,000USD | 6,229,000USD |
| Property Plant Equipment Gross | — | 16,400,000USD | 16,634,000USD | 17,692,000USD | 17,078,000USD | 17,102,000USD | 17,036,000USD | 15,982,000USD |
| Common Stock Shares Outstanding | — | 305,409shares | 30,384,208shares | 28,393,445shares | 26,367,548shares | 26,253,565shares | 26,146,234shares | 25,983,929shares |
| Non Current Assets Total | — | 19,897,000USD | 20,902,000USD | 22,361,000USD | 21,881,000USD | 21,589,000USD | 22,711,000USD | 17,126,000USD |
| Non Current Liabilities Total | — | 8,039,000USD | 10,365,000USD | 8,563,000USD | 8,424,000USD | 51,171,000USD | 55,054,000USD | 51,683,000USD |
| Non Currrent Assets Other | — | 3,578,000USD | 3,728,000USD | 4,145,000USD | 3,752,000USD | 2,892,000USD | 3,552,000USD | 3,605,000USD |
| Net Working Capital | — | -35,024,000USD | -27,187,000USD | -20,464,000USD | -26,349,000USD | 25,011,000USD | 36,842,000USD | 46,784,000USD |
| Unclassified Current Liabilities | — | -46,139,000USD | -42,984,000USD | -42,449,000USD | -42,216,000USD | — | — | — |
| Unclassified Non Current Liabilities | — | 8,039,000USD | 7,365,000USD | 8,563,000USD | 8,424,000USD | 9,707,000USD | 9,809,000USD | 9,136,000USD |
| Unclassified Equity | — | 395,192,000USD | 393,112,000USD | 391,498,000USD | 372,774,000USD | 369,509,000USD | 366,246,000USD | 362,511,000USD |
| Non Current Liabilities Other | — | — | 3,000,000USD | — | — | — | 3,000,000USD | — |
| Long Term Debt | — | — | — | — | — | 41,464,000USD | 42,245,000USD | 42,547,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | -1,939,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-06-30 · AUD | FY 20212021-12-31 · AUD | FY 20202020-12-31 · AUD | FY 20192019-12-31 · AUD | FY 20182018-12-31 · AUD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 56,392,000USD | 79,711,000USD | 111,640,000USD | 82,462,000AUD | 116,015,000AUD | 82,462,000AUD | 25,784,000AUD | — |
| Intangible Assets | 5,645,000USD | 5,570,000USD | 487,000USD | — | 443,000AUD | 364,000AUD | 225,000AUD | — |
| Other Current Assets | 1,272,000USD | 3,822,000USD | 1,432,000USD | 203,000AUD | 1,414,000AUD | 1,116,000AUD | 672,077AUD | 1,098,000AUD |
| Total Liab | 73,042,000USD | 75,212,000USD | 62,584,000USD | — | 11,391,000AUD | 10,061,000AUD | 4,952,000AUD | — |
| Total Stockholder Equity | -16,650,000USD | 4,499,000USD | 49,056,000USD | — | 104,624,000AUD | 72,401,000AUD | 20,832,000AUD | — |
| Other Current Liab | 9,805,000USD | 12,964,000USD | 8,478,000USD | 355,000AUD | 5,718,000AUD | 3,376,000AUD | 2,565,000AUD | — |
| Common Stock | 3,000USD | 3,000USD | 3,000USD | 3,000AUD | 3,000AUD | 3,000AUD | 3,000AUD | — |
| Capital Stock | 3,000USD | 3,000USD | 3,000USD | — | 3,000AUD | 3,000AUD | 143,064,598AUD | — |
| Retained Earnings | -408,401,000USD | -359,814,000USD | -297,969,000USD | -235,923,000AUD | -235,923,000AUD | -194,913,000AUD | -152,828,000AUD | — |
| Cash | 10,243,000USD | 14,050,000USD | 22,118,000USD | — | 55,511,000AUD | 73,639,000AUD | 20,174,000AUD | — |
| Cash And Short Term Investments | 18,185,000USD | 35,885,000USD | 89,057,000USD | — | 85,160,000AUD | 73,639,000AUD | 20,174,000AUD | — |
| Total Current Assets | 35,490,000USD | 57,000,000USD | 104,006,000USD | 92,132,000AUD | 92,132,000AUD | 78,387,000AUD | 24,125,000AUD | — |
| Total Current Liabilities | 62,677,000USD | 20,158,000USD | 13,199,000USD | 9,146,000AUD | 9,146,000AUD | 7,709,000AUD | 4,481,000AUD | — |
| Net Debt | 35,805,000USD | 31,935,000USD | 20,291,000USD | — | -53,873,000AUD | -71,722,000AUD | -20,174,000AUD | — |
| Short Term Debt | 43,913,000USD | 900,000USD | 895,000USD | — | 720,000AUD | — | 0AUD | — |
| Short Long Term Debt | 42,984,000USD | — | — | — | — | — | 0AUD | — |
| Short Long Term Debt Total | 46,048,000USD | 45,985,000USD | 42,409,000USD | — | 1,638,000AUD | 1,917,000AUD | 37,858AUD | — |
| Short Term Investments | 7,942,000USD | 21,835,000USD | 66,939,000USD | — | 29,649,000AUD | 0AUD | 0AUD | — |
| Net Receivables | 9,107,000USD | 11,963,000USD | 7,921,000USD | 3,513,000AUD | 3,426,000AUD | 2,507,000AUD | 2,536,923AUD | — |
| Inventory | 6,926,000USD | 7,269,000USD | 5,596,000USD | 2,132,000AUD | 2,132,000AUD | 1,125,000AUD | 742,000AUD | — |
| Accounts Payable | 8,959,000USD | 6,294,000USD | 3,793,000USD | 2,708,000AUD | 2,708,000AUD | 4,333,000AUD | 1,916,000AUD | — |
| Property Plant Equipment Net | 11,529,000USD | 13,589,000USD | 4,317,000USD | 2,806,000AUD | 2,806,000AUD | 3,710,000AUD | 1,309,000AUD | — |
| Property Plant Equipment Gross | 16,634,000USD | 17,036,000USD | 6,749,000USD | — | 2,938,000AUD | 3,710,000AUD | 1,287,584AUD | — |
| Accumulated Other Comprehensive Income | -1,367,000USD | -1,939,000USD | -1,887,000USD | — | 8,060,000AUD | 8,146,000AUD | 8,184,000AUD | — |
| Common Stock Shares Outstanding | 27,860,784shares | 25,883,056shares | 25,331,264shares | — | 24,356,475shares | 20,290,966shares | 22,330,817shares | — |
| Non Current Assets Total | 20,902,000USD | 22,711,000USD | 7,634,000USD | — | 23,883,000AUD | 4,075,000AUD | 1,659,000AUD | — |
| Non Current Liabilities Total | 10,365,000USD | 55,054,000USD | 49,385,000USD | — | 2,245,000AUD | 2,352,000AUD | 471,000AUD | — |
| Non Current Liabilities Other | 3,000,000USD | 3,000,000USD | — | — | 503,000AUD | 503,000AUD | 42,000AUD | 42,000AUD |
| Non Currrent Assets Other | 3,728,000USD | 3,552,000USD | 2,830,000USD | — | 942,000AUD | 1,000AUD | 125,000AUD | — |
| Net Working Capital | -27,187,000USD | 36,842,000USD | 90,807,000USD | — | 113,940,000AUD | 70,678,000AUD | 19,816,064AUD | — |
| Unclassified Current Liabilities | -42,984,000USD | — | — | 6,083,000AUD | — | — | — | — |
| Unclassified Non Current Liabilities | 7,365,000USD | 9,809,000USD | 9,573,000USD | — | — | 1,414,000AUD | — | — |
| Unclassified Equity | 393,112,000USD | 366,246,000USD | 348,906,000USD | — | 332,481,000AUD | 259,162,000AUD | 22,408,402AUD | — |
| Long Term Debt | — | 42,245,000USD | 39,812,000USD | — | — | — | 0AUD | — |
| Unclassified Current Assets | — | -1,939,000USD | — | 86,284,000AUD | — | — | — | — |
| Current Deferred Revenue | — | — | 33,000USD | — | — | — | — | — |
| Long Term Investments | — | — | 0USD | — | 0AUD | 0AUD | 0AUD | — |
| Deferred Long Term Liab | — | — | — | 504,000AUD | 613,000AUD | — | 0AUD | — |
| Other Liab | — | — | — | 1,327,000AUD | 1,578,000AUD | 435,000AUD | 471,000AUD | — |
| Other Assets | — | — | — | 942,000AUD | 761,000AUD | 0AUD | 0AUD | — |
| Net Tangible Assets | — | — | — | 104,181,000AUD | 115,183,000AUD | 72,037,000AUD | 20,607,000AUD | — |
| Unclassified Non Current Assets | — | — | — | — | 18,931,000AUD | — | — | — |
| Good Will | — | — | — | — | — | — | 0AUD | — |
| Accumulated Depreciation | — | — | — | — | — | — | 0AUD | — |
| Additional Paid In Capital | — | — | — | — | — | — | 0AUD | — |
| Treasury Stock | — | — | — | — | — | — | 0AUD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -10,611,000USD | -11,621,000USD | -13,187,000USD | -9,920,000USD | -13,859,000USD | -11,589,000USD | -16,205,000USD | -15,393,000USD |
| Depreciation | 627,000USD | 392,000USD | 574,000USD | 552,000USD | 521,000USD | 409,000USD | 310,000USD | 204,000USD |
| Stock Based Compensation | 1,101,000USD | 1,373,000USD | 2,777,000USD | 2,675,000USD | 2,694,000USD | 2,798,000USD | 4,080,000USD | 4,027,000USD |
| Other Non Cash Items | 1,042,000USD | 383,000USD | 3,665,000USD | -1,747,000USD | 94,000USD | 1,047,000USD | 2,237,000USD | -1,567,000USD |
| Change To Account Receivables | -799,000USD | -81,000USD | 2,341,000USD | 1,626,000USD | -253,000USD | -1,434,000USD | -1,530,000USD | -1,710,000USD |
| Change To Inventory | 752,000USD | 198,000USD | 144,000USD | 629,000USD | -1,439,000USD | -1,119,000USD | 306,000USD | 312,000USD |
| Change In Working Capital | -2,231,000USD | 4,035,000USD | 952,000USD | -1,789,000USD | 241,000USD | -746,000USD | 2,364,000USD | -51,000USD |
| Total Cash From Operating Activities | -10,072,000USD | -5,438,000USD | -5,219,000USD | -10,229,000USD | -10,309,000USD | -8,081,000USD | -7,214,000USD | -12,780,000USD |
| Capital Expenditures | -22,000USD | 1,713,000USD | -955,000USD | -524,000USD | -234,000USD | -1,634,000USD | -3,816,000USD | -2,653,000USD |
| Free Cash Flow | -10,094,000USD | -3,725,000USD | -6,174,000USD | -10,753,000USD | -10,543,000USD | -9,715,000USD | -11,030,000USD | -15,433,000USD |
| Investments | 2,063,000USD | 37,000USD | -4,386,000USD | 7,016,000USD | 10,766,000USD | 2,471,000USD | 7,394,000USD | 12,432,000USD |
| Total Cashflows From Investing Activities | 2,041,000USD | 11,000USD | -5,341,000USD | 7,016,000USD | 10,766,000USD | 2,471,000USD | 7,394,000USD | 12,432,000USD |
| Net Borrowings | 6,097,000USD | — | — | — | 0USD | — | — | — |
| Total Cash From Financing Activities | 6,097,000USD | 248,000USD | 13,766,000USD | 559,000USD | 363,000USD | 1,021,000USD | 1,007,000USD | 849,000USD |
| Change In Cash | -1,934,000USD | -5,179,000USD | 3,206,000USD | -2,654,000USD | 820,000USD | -4,589,000USD | 1,187,000USD | 501,000USD |
| Begin Period Cash Flow | 10,243,000USD | 15,422,000USD | 12,216,000USD | 14,870,000USD | 14,050,000USD | 18,639,000USD | 17,452,000USD | 16,951,000USD |
| End Period Cash Flow | 8,309,000USD | 10,243,000USD | 15,422,000USD | 12,216,000USD | 14,870,000USD | 14,050,000USD | 18,639,000USD | 17,452,000USD |
| Other Cashflows From Investing Activities | -3,000USD | -1,710,000USD | -16,000USD | — | -13,000USD | -22,000USD | -56,000USD | -1,000USD |
| Other Cashflows From Financing Activities | 6,097,000USD | 281,276USD | -285,221USD | 544,036USD | 363,000USD | 1,021,000USD | 1,007,000USD | 849,000USD |
| Unclassified Financing Cash Flow | -6,097,000USD | — | 14,051,221USD | — | — | — | — | — |
| Issuance Of Capital Stock | — | 0USD | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | 1,656,000USD | 3,872,000USD | 2,654,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-06-30 · AUD | FY 20212021-12-31 · AUD | FY 20202020-12-31 · AUD | FY 20192019-12-31 · AUD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -48,587,000USD | -61,845,000USD | -35,381,000USD | -28,854,000AUD | -25,142,000AUD | -42,030,000AUD | -35,902,972AUD | -34,603,140USD |
| Depreciation | 2,039,000USD | 1,126,000USD | 632,000USD | 673,000AUD | 969,000AUD | 465,000AUD | 384,746AUD | — |
| Stock Based Compensation | 9,519,000USD | 13,496,000USD | 8,384,000USD | — | 6,331,000AUD | 16,593,000AUD | 2,783,331AUD | — |
| Other Non Cash Items | 2,395,000USD | 2,962,000USD | -5,072,000USD | — | 1,533,000AUD | 895,000AUD | 706,559AUD | — |
| Change To Account Receivables | 3,633,000USD | -4,171,000USD | -3,304,000USD | -1,193,000AUD | -1,193,000AUD | -582,000AUD | 2,821,949AUD | — |
| Change To Inventory | -468,000USD | -2,160,000USD | -3,693,000USD | -144,000AUD | -144,000AUD | -468,000AUD | 24,314AUD | — |
| Change In Working Capital | 3,439,000USD | -4,678,000USD | -6,574,000USD | -1,030,000AUD | -1,728,000AUD | 1,330,000AUD | 4,679,887AUD | — |
| Total Cash From Operating Activities | -31,195,000USD | -48,939,000USD | -38,011,000USD | -18,037,000AUD | -18,037,000AUD | -22,747,000AUD | -27,532,954AUD | — |
| Capital Expenditures | -1,739,000USD | -9,333,000USD | -1,447,000USD | -487,000AUD | -487,000AUD | -847,000AUD | -1,507,987AUD | 0USD |
| Free Cash Flow | -32,934,000USD | -58,272,000USD | -39,458,000USD | — | -18,524,000AUD | -23,594,000AUD | -29,628,648AUD | — |
| Investments | 14,191,000USD | 37,363,000USD | 1,607,000USD | -49,550,000AUD | -1,174,000AUD | -847,000AUD | -1,256,835AUD | — |
| Total Cashflows From Investing Activities | 12,452,000USD | 37,363,000USD | 1,607,000USD | -50,208,000AUD | -50,208,000AUD | -847,000AUD | -1,836,070AUD | — |
| Total Cash From Financing Activities | 14,936,000USD | 3,508,000USD | 40,374,000USD | 64,065,000AUD | 64,065,000AUD | 77,057,000AUD | 42,492,287AUD | — |
| Issuance Of Capital Stock | 14,792,000USD | 0USD | — | — | 69,106,000AUD | 81,702,000AUD | 31,541,086AUD | 32,453,000USD |
| Change In Cash | -3,807,000USD | -8,068,000USD | 3,954,000USD | -4,254,000AUD | 37,107,000AUD | 53,466,000AUD | 13,427,499AUD | — |
| Begin Period Cash Flow | 14,050,000USD | 22,118,000USD | 18,164,000USD | 110,947,000AUD | 73,840,000AUD | 20,374,000AUD | 15,713,092AUD | 14,843,184USD |
| End Period Cash Flow | 10,243,000USD | 14,050,000USD | 22,118,000USD | 55,712,000AUD | 110,947,000AUD | 73,840,000AUD | 29,140,592AUD | 10,382,898USD |
| Other Cashflows From Investing Activities | -734,000USD | -162,000USD | -66,000USD | — | -49,721,000AUD | -257,000AUD | 0AUD | — |
| Other Cashflows From Financing Activities | 795,000USD | 3,508,000USD | 1,612,000USD | -5,109,000AUD | 64,076,000AUD | -4,603,000AUD | 329,698AUD | — |
| Net Borrowings | — | 0USD | 38,762,000USD | -2,000AUD | -11,000AUD | -42,000AUD | -62,000AUD | — |
| Unclassified Investing Cash Flow | — | 9,495,000USD | 1,513,000USD | — | 1,174,000AUD | 1,104,000AUD | — | — |
| Change To Liabilities | — | — | — | 307,000AUD | -693,000AUD | 2,435,000AUD | 2,240,000AUD | — |
| Unclassified Operating Cash Flow | — | — | — | 11,174,000AUD | — | — | — | — |
| Unclassified Financing Cash Flow | — | — | — | 69,176,000AUD | -69,106,000AUD | — | 41,001,161AUD | — |
| Dividends Paid | — | — | — | — | — | — | 0AUD | — |
| Sale Purchase Of Stock | — | — | — | — | — | — | 1,223,428AUD | — |
| Exchange Rate Changes | — | — | — | — | — | — | 0AUD | — |
| Cash And Cash Equivalents Changes | — | — | — | — | — | — | 0AUD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Geography | Australia | 194,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | European Union | 182,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | Japan | 387,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | United Kingdom | 93,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | United States | 20,846,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Cohealyx | 1,744,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Lease Revenue | 213,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Permeaderm | 607,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Recell System | 19,049,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | Australia | 40,000 | USD | 0001193125-26-224107 |
| Q1 2026Quarterly · 2026-03-31 | Geography | European Union | 0 | USD | 0001193125-26-224107 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Japan | 439,000 | USD | 0001193125-26-224107 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United Kingdom | 202,000 | USD | 0001193125-26-224107 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 18,570,000 | USD | 0001193125-26-224107 |
| Q1 2026Quarterly · 2026-03-31 | Product | Lease Revenue | 187,000 | USD | 0001193125-26-224107 |
| Q1 2026Quarterly · 2026-03-31 | Product | Other Wound Care Products | 1,935,000 | USD | 0001193125-26-224107 |
| Q1 2026Quarterly · 2026-03-31 | Product | Recell System | 17,121,000 | USD | 0001193125-26-224107 |
| Q4 2025Quarterly · 2025-12-31 | Product | Lease Revenue | 185,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Other Wound Care Products | 911,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Recell System | 16,540,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | Australia | 200,000 | USD | 0001193125-26-049031 |
| FY 2025Yearly · 2025-12-31 | Geography | European Union | 49,000 | USD | 0001193125-26-049031 |
| FY 2025Yearly · 2025-12-31 | Geography | Japan | 2,088,000 | USD | 0001193125-26-049031 |
| FY 2025Yearly · 2025-12-31 | Geography | United Kingdom | 486,000 | USD | 0001193125-26-049031 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 68,787,000 | USD | 0001193125-26-049031 |
| FY 2025Yearly · 2025-12-31 | Product | Lease Revenue | 731,000 | USD | 0001193125-26-049031 |
| FY 2025Yearly · 2025-12-31 | Product | Other Wound Care Products | 4,246,000 | USD | 0001193125-26-049031 |
| FY 2025Yearly · 2025-12-31 | Product | Recell System | 66,461,000 | USD | 0001193125-26-049031 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Australia | 80,000 | USD | 0001193125-25-269597 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Japan | 605,000 | USD | 0001193125-25-269597 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United Kingdom | 345,000 | USD | 0001193125-25-269597 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 16,032,000 | USD | 0001193125-25-269597 |
| Q3 2025Quarterly · 2025-09-30 | Product | Lease Revenue | 165,000 | USD | 0001193125-25-269597 |
| Q3 2025Quarterly · 2025-09-30 | Product | Other Wound Care Products | 1,406,000 | USD | 0001193125-25-269597 |
| Q3 2025Quarterly · 2025-09-30 | Product | Recell System | 15,427,000 | USD | 0001193125-25-269597 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Australia | 40,000 | USD | 0001762303-25-000014 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Japan | 427,000 | USD | 0001762303-25-000014 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United Kingdom | 55,000 | USD | 0001762303-25-000014 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 17,896,000 | USD | 0001762303-25-000014 |
| Q2 2025Quarterly · 2025-06-30 | Product | Lease Revenue | 192,000 | USD | 0001762303-25-000014 |
| Q2 2025Quarterly · 2025-06-30 | Product | Other Wound Care Products | 1,343,000 | USD | 0001762303-25-000014 |
| Q2 2025Quarterly · 2025-06-30 | Product | Recell System | 16,819,000 | USD | 0001762303-25-000014 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Australia | 40,000 | USD | 0001193125-26-224107 |
| Q1 2025Quarterly · 2025-03-31 | Geography | European Union | 49,000 | USD | 0001193125-26-224107 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Japan | 634,000 | USD | 0001193125-26-224107 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United Kingdom | 35,000 | USD | 0001193125-26-224107 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 17,756,000 | USD | 0001193125-26-224107 |
| Q1 2025Quarterly · 2025-03-31 | Product | Lease Revenue | 189,000 | USD | 0001193125-26-224107 |
| Q1 2025Quarterly · 2025-03-31 | Product | Other Wound Care Products | 586,000 | USD | 0001193125-26-224107 |
| Q1 2025Quarterly · 2025-03-31 | Product | Recell System | 17,675,000 | USD | 0001193125-26-224107 |
| Q4 2024Quarterly · 2024-12-31 | Geography | Australia | 180,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | European Union | 1,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | Japan | 193,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | United Kingdom | 37,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | United States | 17,995,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Australia | 312,000 | USD | 0001193125-26-049031 |
| FY 2024Yearly · 2024-12-31 | Geography | European Union | 155,000 | USD | 0001193125-26-049031 |
| FY 2024Yearly · 2024-12-31 | Geography | Japan | 1,431,000 | USD | 0001193125-26-049031 |
| FY 2024Yearly · 2024-12-31 | Geography | United Kingdom | 196,000 | USD | 0001193125-26-049031 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 62,157,000 | USD | 0001193125-26-049031 |
| FY 2024Yearly · 2024-12-31 | Product | Lease Revenue | 358,000 | USD | 0001193125-26-049031 |
| FY 2024Yearly · 2024-12-31 | Product | Other Wound Care Products | 1,054,000 | USD | 0001193125-26-049031 |
| FY 2024Yearly · 2024-12-31 | Product | Recell System | 62,611,000 | USD | 0001193125-26-049031 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Australia | 54,000 | USD | 0001193125-25-269597 |
| Q3 2024Quarterly · 2024-09-30 | Geography | European Union | 0 | USD | 0001193125-25-269597 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Japan | 388,000 | USD | 0001193125-25-269597 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United Kingdom | 56,000 | USD | 0001193125-25-269597 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 19,048,000 | USD | 0001193125-25-269597 |
| Q3 2024Quarterly · 2024-09-30 | Product | Lease Revenue | 152,000 | USD | 0001193125-25-269597 |
| Q3 2024Quarterly · 2024-09-30 | Product | Other Wound Care Products | 271,000 | USD | 0001193125-25-269597 |
| Q3 2024Quarterly · 2024-09-30 | Product | Recell System | 19,059,000 | USD | 0001193125-25-269597 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Australia | 61,000 | USD | 0001762303-25-000014 |
| Q2 2024Quarterly · 2024-06-30 | Geography | European Union | 103,000 | USD | 0001762303-25-000014 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Japan | 389,000 | USD | 0001762303-25-000014 |
| Q2 2024Quarterly · 2024-06-30 | Geography | United Kingdom | 60,000 | USD | 0001762303-25-000014 |
| Q2 2024Quarterly · 2024-06-30 | Geography | United States | 14,582,000 | USD | 0001762303-25-000014 |
| Q2 2024Quarterly · 2024-06-30 | Product | Lease Revenue | 12,000 | USD | 0001762303-25-000014 |
| Q2 2024Quarterly · 2024-06-30 | Product | Other Wound Care Products | 328,000 | USD | 0001762303-25-000014 |
| Q2 2024Quarterly · 2024-06-30 | Product | Recell System | 14,791,000 | USD | 0001762303-25-000014 |
| FY 2023Yearly · 2023-12-31 | Geography | Australia | 222,000 | USD | 0000950170-25-020026 |
| FY 2023Yearly · 2023-12-31 | Geography | European Union | 51,000 | USD | 0000950170-25-020026 |
| FY 2023Yearly · 2023-12-31 | Geography | Japan | 3,370,000 | USD | 0000950170-25-020026 |
| FY 2023Yearly · 2023-12-31 | Geography | United Kingdom | 141,000 | USD | 0000950170-25-020026 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 46,359,000 | USD | 0000950170-25-020026 |
| FY 2022Yearly · 2022-12-31 | Geography | Australia | 275,000 | AUD | 0000950170-24-018748 |
| FY 2022Yearly · 2022-12-31 | Geography | Japan | 729,000 | AUD | 0000950170-24-018748 |
| FY 2022Yearly · 2022-12-31 | Geography | United Kingdom | 160,000 | AUD | 0000950170-24-018748 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 33,257,000 | AUD | 0000950170-24-018748 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.